Heterozygous mutation in the WSXWS equivalaent motif of the growth hormone receptor in a child with poor response to growth hormone therapy.
Besides complete GH insensitivity syndrome (GHIS) described by Laron, clinical and molecular evidences have accumulated concerning partial GHIS. We studied GH receptor (GHR) gene in children who show poor response to GH treatment and detected a patient with a heterozygous mutation in exon 7 leading to the Y222H substitution. This missense mutation, located in the YGEFS motif of the GHR equivalent to the WSXWS motif highly conserved throughout all members of the cytokine receptor family, has not been described so far. Although we cannot conclude on the deleterious effect of this mutation, there are several lines of evidence suggesting that it could account for the partial GH insensitivity: (i) hormonal data including IGF-I generation test; (ii) molecular data - no other mutation was identified in the coding sequence, the father who has the same mutation is short, the brother did not inherit the mutated allele and was of normal height.
Tauber
M T
MT
Service d'Endocrinologie pédiatrique, CHU Purpan, Toulouse, France. tauber.mt@chu.toulouse.fr
Porra
V
V
Dastot
F
F
Molinas
C
C
Amselem
S
S
Cholin
S
S
Rochiccioli
P
P
Bieth
E
E
D020816:Amino Acid Motifs; D002352:Carrier Proteins / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005091:Exons; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy / Q000235:genetics*; D006579:Heterozygote; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D020125:Mutation, Missense; D011247:Pregnancy; D011986:Receptors, Somatotropin / Q000235:genetics*
D002352:Carrier Proteins; D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; C051815:somatotropin-binding protein